Google Custom Search
Podcast Advocacy 2014 HBV Meeting navigation menu

Home

PA Biotech
Liver Cancer Connect
Visit our Baruch Blumberg Institute of Living Science
World Hepatitis Alliance Member
HepB United

 

 

 

 

Research and Eucation

 

Seminar Series Schedule 2009

January 8 - 11:00 AM - Chuck Reynolds, PhD (Johnson & Johnson)
"Application of Computer Modeling in Drug Discovery"

January 30 - 11:00 AM - Yvonne Paterson, PhD (Dept. of Microbiology, University of Pennsylvania School of Medicine)
"A Multi-Pronged Approach to Tumor Immunotherapy Using Listeria Monocytogenes as an Antigen Delivery Vehicle"

February 13 - 11:00 AM - Sandhya Kortagere, PhD (Microbiology and Immunology, Drexel University College of Medicine)
"Hybrid Structure Based Method and its Application to Design New Lead Compounds"

March 3 - 11:00 AM - Brian Haab, PhD (Laboratory of Cancer Immunodiagnostics, Van Andel Institute)
"The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Glycan Sandwich Arrays"

March 11 - 11:00 AM - Wai Law, PhD (PortaScience, Inc.)
"Point-of-Care Testing for WBCs"

March 19 - 4:00 PM - Dr. Stephen Locarnini (Victorian Infectious Diseases Reference Laboratory/WHO Collaborating Centre for Virus Reference & Research)
"The Virology of Hepatitis B Immunomodulation and Therapy"
Hepatitis B Foundation's 2009 Bruce Witte Lecturer

March 25 - 11:00 AM - Dr. Wolfram Gerlich (Institute for Medical Virology, Geissen, Germany)
"Escape Mutants in Occult and Reactivated Hepatitis B Virus Infection"

April 8 - 11:00 AM - Dr. Harvey Friedman (Infectious Disease Division, University of Pennsylvania School of Medicine
"TBA"

April 16 - 11:00 AM - Paul Ahlquist, PhD (Institute for Molecular Virology, University of Wisconsin)
"TBA"

April 27 - 11:00 AM - Raymond Dwek, FRS (Oxford Glycobiology Institute, University of Oxford)
"Glycobiology - Leading to Novel Therapies for Hepatitis and HIV"

May 20 - 11:00 AM - Dr. David Kaplan (Gastroenterology Division, University of Pennsylvania School of Medicine)
"Dysfunctional Tumor Antigen-Specific T-Cell Responses in Hepatocellular Carcinoma"

May 27 - 11:00 AM - Bart DeCorte, PhD (Pharmaceutical Research & Development, Johnson & Johnson)
"The Long Road to Intelence®, a Next-Generation NNRTI for the Treatment of HIV"

June 17 - 11:00 AM - Terry Butters, PhD (Glycobiology Institute, University of Oxford)
"Therapeutic Potential of Protein Folding Inhibitors"

June 26 - 11:00 AM - Dr. Michael Fried (University of North Carolina at Chapel Hill)
"HBV Treatment Guidelines: Navigating the Twilight Zone"

July 16 - 11:00 AM - Gary Jacob, PhD (Synergy Pharmaceuticals, Inc.)
"What a Lifetime in Drug Development Has Taught Me...Or, What They Don't Teach You in Graduate School"

August 19 - 11:00 AM - Stephen Lee, PhD (OraSure Technologies, Inc.)
"Recent Developments in Point of Care Testing for HIV and Hepatitis"

September 16 - 11:00 AM - Bruce Maryanoff, PhD (Johnson & Johnson Pharmaceutical Research & Development)
"An Odyssey in Drug Discovery Through Serine-Protease Space"

September 18 - 8:30 AM - 2009 Annual Regional Biotech Conference*
"A Roadmap for Biotechnology Ventures"

September 23 - 11:00 AM - Luis Montaner, DVM (The Wistar Institute)
"Innate Immune Effectors and HIV-1: From Viral Replication to ART and Back"

September 30 - 11:00 AM - James Arthos, PhD (Laboratory of Immunoregulation, NIAID, NIH
"The Role of Integrin in Alpha4beta7 in HIV-1 Transmission"

October 5 - 11:00 AM - James Barrett, PhD (Drexel University College of Medicine)
"Development of Drugs to Treat Cognitive Disorders Associated with Psychiatric and Neurological Diseases"

October 15 - 11:00 AM - Daniel Flynn, PhD (Commonwealth Medical College)
"Defining the Cellular Function of AFAP1: A Potential Drug Target for Breast and Ovarian Cancer "

October 21 - 11:00 AM - Rene Daniel, MD, PhD (Thomas Jefferson University, Jefferson Medical College)
"Epigenetics in Gene Transfer and Stem Cell Differentiation"

October 29 - 11:00 AM - Hie-Won Hann, MD (Thomas Jefferson University, Jefferson Medical College)
"Antiviral Therapy for Hepatitis B and Hepatocellular Carcinoma"

November 2 - 11:00 AM - Maria Maccecchini, PhD (President & CEO, QR Pharma)*
"Pathways Leading to Alzheimer's Disease"

November 12 - 11:00 AM - D. Craig Hooper, PhD (WHO Center for Neurovirology, Thomas Jefferson University)
"Delivery of Therapeutics Across the Blood-Brain Barrier by Immune Mechanisms"

November 19 - 4:00 PM - Allen Reitz, PhD (ALS BioPharma)*
"The Pennsylvania Center for Drug Discovery: Public Private Partnerships to Accelerate Innovation"

November 30 - 11:00 AM - Melik Demirel, PhD (Penn State University)
"Pathogen Sensing Via Ramen Activated Nanoparticles (RANs)"

December 17 - 11:00 AM - Lin Li, PhD (University of Pennsylvania)
"Novel Biomarkers of Cancer Metastatic Potential by MR/Optical Imaging"

December 21 - 4:00 PM - Herb Taylor, PhD (VP, Federal Reserve Bank of Philadelphia)*
"Outlook For The U.S. Economy"

*Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)

Back to top

 


donate
amazon smile

Connect with Us

facebook twitter youtube linkedin
Hep B Blog
Bookmark and Share
Site design by Ferguson Lynch  FL logo